相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome
Gijsbert J. A. Nagtegaal et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression
Alberto Ascherio et al.
JAMA NEUROLOGY (2014)
Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease
Adam E. Handel et al.
BMC MEDICINE (2013)
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls
Dorothee Nickles et al.
HUMAN MOLECULAR GENETICS (2013)
Expression of Vitamin D Receptor and Metabolizing Enzymes in Multiple Sclerosis-Affected Brain Tissue
Joost Smolders et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes
Jun-ichi Satoh et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis
Beatriz Pozuelo-Moyano et al.
NEUROEPIDEMIOLOGY (2013)
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
Andrea Franceschini et al.
NUCLEIC ACIDS RESEARCH (2013)
Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis
E. Croze et al.
PHARMACOGENOMICS JOURNAL (2013)
Intrathecal levels of vitamin D and IgG in multiple sclerosis
T. Holmoy et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis
Ellen M. Mowry et al.
ANNALS OF NEUROLOGY (2012)
Lactoferrin, a key molecule in immune and inflammatory processes
Dominique Legrand
BIOCHEMISTRY AND CELL BIOLOGY (2012)
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
Merja Soilu-Hanninen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
The initiation and prevention of multiple sclerosis
Alberto Ascherio et al.
NATURE REVIEWS NEUROLOGY (2012)
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis
Tessel F. Runia et al.
NEUROLOGY (2012)
Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis
Joost Smolders et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis
M. Mehling et al.
NEUROLOGY (2011)
Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy
Sami Heikkinen et al.
NUCLEIC ACIDS RESEARCH (2011)
Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53
Perry Stambolsky et al.
CANCER CELL (2010)
Vitamin D and the Immune System: New Perspectives on an Old Theme
Martin Hewison
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2010)
A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution
Sreeram V. Ramagopalan et al.
GENOME RESEARCH (2010)
The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis
Kaushal S. Gandhi et al.
HUMAN MOLECULAR GENETICS (2010)
Fingolimod is a potential novel therapy for multiple sclerosis
Orhan Aktas et al.
NATURE REVIEWS NEUROLOGY (2010)
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
J. M. Burton et al.
NEUROLOGY (2010)
A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
M. Comabella et al.
BRAIN (2009)
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
Ludwig Kappos et al.
LANCET NEUROLOGY (2009)
MEME SUITE: tools for motif discovery and searching
Timothy L. Bailey et al.
NUCLEIC ACIDS RESEARCH (2009)
A vitamin D nutritional cornucopia: new insights concerning the serum 25-hydroxyvitamin D status of the US population
Anthony W. Norman
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
Pharmacogenomics of Interferon-β Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
Lisa G. M. van Baarsen et al.
PLOS ONE (2008)
JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update
Jan Christian Bryne et al.
NUCLEIC ACIDS RESEARCH (2008)
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis:: a 3-year follow-up analysis of the BENEFIT study
Ludwig Kappos et al.
LANCET (2007)
Vitamin D deficiency
Michael F. Holick
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Minireview: vitamin D receptor: New assignments for an already busy receptor
Anthony W. Norman
ENDOCRINOLOGY (2006)
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
L. Kappos et al.
NEUROLOGY (2006)
A subtype of multiple sclerosis defined by an activated immune defense program
L. G. M. van Baarsen et al.
GENES AND IMMUNITY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
MH Dai et al.
NUCLEIC ACIDS RESEARCH (2005)
Enzymes involved in the activation and inactivation of vitamin D
DE Prosser et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad et al.
BIOINFORMATICS (2003)
Seasonal variation in immune measurements and MRI markers of disease activity in MS
J Killestein et al.
NEUROLOGY (2002)
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
PA Brex et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study
G Comi et al.
LANCET (2001)
分享论文
